JP2025515029A5 - - Google Patents
Info
- Publication number
- JP2025515029A5 JP2025515029A5 JP2024564653A JP2024564653A JP2025515029A5 JP 2025515029 A5 JP2025515029 A5 JP 2025515029A5 JP 2024564653 A JP2024564653 A JP 2024564653A JP 2024564653 A JP2024564653 A JP 2024564653A JP 2025515029 A5 JP2025515029 A5 JP 2025515029A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- cdr1
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338359P | 2022-05-04 | 2022-05-04 | |
| US63/338,359 | 2022-05-04 | ||
| US202363444520P | 2023-02-09 | 2023-02-09 | |
| US202363444521P | 2023-02-09 | 2023-02-09 | |
| US63/444,520 | 2023-02-09 | ||
| US63/444,521 | 2023-02-09 | ||
| US202363495763P | 2023-04-12 | 2023-04-12 | |
| US202363495765P | 2023-04-12 | 2023-04-12 | |
| US63/495,765 | 2023-04-12 | ||
| US63/495,763 | 2023-04-12 | ||
| PCT/US2023/066549 WO2023215787A1 (en) | 2022-05-04 | 2023-05-03 | Compositions and methods for selective regulation of vascular permeability |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025515029A JP2025515029A (ja) | 2025-05-13 |
| JP2025515029A5 true JP2025515029A5 (cg-RX-API-DMAC7.html) | 2026-05-15 |
Family
ID=88647182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564653A Pending JP2025515029A (ja) | 2022-05-04 | 2023-05-03 | 血管透過性の選択的調節のための組成物及び方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250282885A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4519320A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025515029A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023215787A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2017224122B2 (en) * | 2016-02-26 | 2024-04-11 | The Board Of Regents Of The University Of Texas System | Connexin (Cx) 43 hemichannel-binding antibodies and uses thereof |
| JP2023537452A (ja) * | 2020-05-22 | 2023-09-01 | イエール ユニバーシティ | 血管漏出を処置するための方法および組成物 |
| AU2021328375A1 (en) * | 2020-08-18 | 2023-04-13 | Cephalon Llc | Anti-PAR-2 antibodies and methods of use thereof |
-
2023
- 2023-05-03 WO PCT/US2023/066549 patent/WO2023215787A1/en not_active Ceased
- 2023-05-03 EP EP23800204.2A patent/EP4519320A1/en active Pending
- 2023-05-03 JP JP2024564653A patent/JP2025515029A/ja active Pending
- 2023-05-03 US US18/862,505 patent/US20250282885A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7852107B2 (ja) | 眼科疾患の処置 | |
| US12145986B2 (en) | Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta) | |
| JP7403553B2 (ja) | 眼科の疾患の個別化された治療 | |
| EA017945B1 (ru) | Композиции и способы лечения и профилактики состояний фиброза, воспаления и неоваскуляризации глаза животного | |
| JP7828274B2 (ja) | 眼疾患を治療するための方法 | |
| AU2020414152B2 (en) | Application of fusion protein in treating age-related macular degeneration | |
| KR20220092872A (ko) | 당뇨망막병증을 치료하기 위한 방법 및 조성물 | |
| JP2021509813A (ja) | 持効性かつ低毒性の組替え型の抗vegfヒト化単クローン抗体及びその調製方法 | |
| WO2025036488A1 (en) | Methods of treating age-related macular degeneration and diabetic macular edema | |
| US20170233467A1 (en) | Antibodies Directed to Angiopoietin-1 and Angiopoietin-2 for Ocular Therapies | |
| WO2018195912A1 (zh) | 一种眼用药物组合物及其用途 | |
| Querques et al. | Intravitreal ranibizumab for choroidal neovascularization associated with retinal astrocytic hamartoma | |
| HK40119700A (zh) | 眼科疾病的个性化治疗 | |
| HK40065038A (en) | Personalized treatment of ophthalmologic diseases |